Atrium Innovations Inc. 

Atrium Innovations develops and commercializes dietary supplements. The nutritional ingredients are developed by multidisciplinary scientists and by an expert biotech production team.

Based in Québec City (Capitale-Nationale), Atrium Innovations is a subsidiary of Aeterna Zentaris, a public company listed on the Toronto Stock Exchange (TSX AEZ) and on NASDAQ (AEZ S). Atrium Innovations distributes its products in America, Europe and Asia.

 
SGF participation: 6% 

www.atrium-bio.com